Damon Runyon, St. Jude establish pediatric cancer fellowship

Andrew Smith named chair of St. Jude Diagnostic Imaging Department

Andrew Smith was named chair of St. Jude’s Diagnostic Imaging Department. He succeeds Beth McCarville, who was interim chair of the department since the death of Zoltan Patay, who held the position from 2017 to 2022.

April 19, 2024

Vol.50 No.16

In Brief

UF Health Proton Therapy Institute adds interactive video wall for pediatric patients

The UF Health Proton Therapy Institute enhanced its playroom, a respite for its pediatric patients, significantly with innovative technology that promotes therapeutic engagement, with an 86” interactive gaming wall that features educational and sensory software.

March 29, 2024

Vol.50 No.13

Clinical Roundup

USC researchers find genetic variant contributing to disparities in childhood leukemia risk

Researchers from the University of Southern California found a genetic variant contributing to disparities in childhood leukemia risk. The variant, located on the IKZF1 gene, helps explain why Hispanic/Latino children face a higher risk of acute lymphoblastic leukemia and offers insights about what causes the disease.

March 29, 2024

Vol.50 No.13

In Brief

Fox Chase’s Joshua Cohn named consultant to Shriners Children’s Philadelphia

Joshua Cohn, associate professor in the Department of Urology at Fox Chase Cancer Center and a member of the Fox Chase – Temple Urologic Institute, was named a consultant at Shriners Children’s Philadelphia.

February 16, 2024

Vol.50 No.07

In Brief

St. Jude adds $13M project to Research Collaboratives program

St. Jude Children’s Research Hospital invested nearly $13 million toward a research collaboration with scientists at Columbia University, Duke University, and Stanford University to expand the understanding of G-protein coupled receptors, which are vital proteins that impact human health and disease.

January 19, 2024

Vol.50 No.03

Clinical Roundup

City of Hope Children’s Cancer Center, Children’s Oncology Group conduct clinical trial seeking to prevent heart failure among pediatric cancer survivors

The largest clinical trial to date seeking to reduce the risk of people who have survived childhood cancer from developing heart failure found that carvedilol, a blood vessel relaxing medication, is safe for childhood cancer survivors and may improve important markers of heart injury sustained as a result of chemotherapy exposure.

January 12, 2024

Vol.50 No.02

Damon Runyon, St. Jude establish pediatric cancer fellowship

YOU MAY BE INTERESTED IN

Andrew Smith named chair of St. Jude Diagnostic Imaging Department

UF Health Proton Therapy Institute adds interactive video wall for pediatric patients

USC researchers find genetic variant contributing to disparities in childhood leukemia risk

Fox Chase’s Joshua Cohn named consultant to Shriners Children’s Philadelphia

St. Jude adds $13M project to Research Collaboratives program

City of Hope Children’s Cancer Center, Children’s Oncology Group conduct clinical trial seeking to prevent heart failure among pediatric cancer survivors

Renew today!

Subscriber content

Login